 |
|
Early feeding could help reduce liver dysfunction in critically ill patients
January 29, 2007Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction. A large study published today in the journal Critical Care recommends that clinicians should strictly control calorie intake, start artificial nutrition within 24 hours and regularly monitor liver function in patients at high risk. The researchers find that patients given enteral nutrition were less likely to suffer from liver dysfunction than those fed through a central venous catheter. Liver dysfunction was more frequent in patients who had sepsis on admission or were fed more than 25kcal/kg a day.
The study was conducted by Teodoro Grau, from the Hospital Severo Ochoa in Madrid, Spain, and colleagues from hospitals in Spain and London, UK. The researchers looked at incidence of liver dysfunction associated with artificial nutrition in 40 intensive care units (ICU) in Spain. Patients were followed until hospital discharge or 28 days after ICU admission. Of 3,409 patients in the study, 725 received artificial nutrition. Of these, 303 received total parental nutrition (TPN) via a central venous catheter, while 422 were given enteral nutrition (EN) through a nasogastric or nasojejunal tube, at the doctor's discretion. 23% (166) of all patients who received artificial nutrition developed liver dysfunction. Rates of liver dysfunction were higher in the TPN group (30%) than in the EN group (18%).
The researchers found that patients who were suffering from sepsis and treated with TPN were at a greater risk of liver dysfunction. Patients receiving TPN were also less nourished.
Liver dysfunction was associated with a longer stay in the ICU and in hospital, but did not increase mortality. Patients who were fed early in their stay had significantly lower incidence of liver dysfunction.
BioMed Central
Liver dysfunction was associated with a longer stay in the ICU and in hospital, but did not increase mortality. Patients who were fed early in their stay had significantly lower incidence of liver dysfunction.
BioMed Central
Second-hand smoking results in liver disease, study finds
A team of scientists at the University of California, Riverside has found that even second-hand tobacco smoke exposure can result in nonalcoholic fatty liver disease (NAFLD), a common disease and rising cause of chronic liver injury in which fat accumulates in the liver of people who drink little or no alcohol.
Are angiotensins involved in the hemodynamic changes of cirrhosis patients?
Liver cirrhosis has been recently studied in the light of the new view of the renin angiotensin system (RAS).
Vaginal progesterone gel may improve infant outcomes
For the first time, data show a positive association between the use of vaginal progesterone and infants' overall health at birth.
Inhaling helps heal liver transplant recipients
A new report from a team of researchers at the University of Washington, Seattle, and the University of Alabama at Birmingham indicates that one of the main complications of liver transplantation can be treated very simply by allowing the transplant recipients to inhale nitric oxide (NO) during the operation in which they received their new liver.
Hurricane aftermath: Infectious disease threats from common, not exotic, diseases
In the wake of Katrina, the public health threats from infectious diseases in hurricane-devastated areas are more likely to come from milder, more common infections rather than exotic diseases. These common infections can often be prevented using simple hygiene measures and a little common sense.
More Liver Dysfunction Current Events and Liver Dysfunction News Articles
 |
Drugs and the Liver: A Guide to Drug Handling in Liver Dysfunction by Penny North-Lewis (Editor) Liver disease is a widespread and increasing problem throughout the world, however little is published on how different types and degrees of liver dysfunction affect the body's ability to handle medicines."Drugs and the Liver" is designed to assist practitioners in making pragmatic choices for their patients. It aims to: enable the practitioner to assess liver function using biochemical markers, other tests, signs, symptoms and disease knowledge; identify which pharmacokinetic and pharmacodynamic parameters of a drug are likely to be affected by different types of liver disease; and consider the impact of a drug's side effects on a patient with liver disease.This practical guide covers background information on liver function, the principles of drug use in liver disease and includes a... |
 |
Metal Detox 30 Caps By Life-FLO Health Care by Life-FLO Health Care Metal Detox is a natural chelation product. It gently removes toxic heavy metals from the body while providing superior mineral supplementation. Metal Detox promotes general health and well being, supports the Defense mechanism of body, and increases mental and physical performance.Heavy metals are known to have a toxic effect on the human body. Such materials are numerous and include: lead, cadmium, mercury, as well as a host of other metals. They are present naturally, as part of the environment in which we live, and also as pollutants. All of the metals mentioned and many others have serious short and long-term negative health effects. Some of the health conditions in which they have been implicated are: cardiac problem, liver dysfunction, a compromised Defense mechanism of body, |
|
Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritis.(Case Report): An article from: Southern Medical Journal by Kohzo Takebayashi (Author), Yoshimasa Aso (Author), Hiroshi Kitamura (Author), Yusei Sakurai (Author), Sadao Wakabayashi (Author), Toshihiko Inukai (Author) This digital document is an article from Southern Medical Journal, published by Southern Medical Association on September 1, 2004. The length of the article is 1850 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritis.(Case Report) Author: Kohzo Takebayashi Publication: Southern Medical Journal (Refereed) Date: September 1, 2004 Publisher: Southern Medical Association Volume: 97 Issue: 9 Page: 911(4) Distributed by Thomson... | |
 |
Using the Non Depolarizing Neuromuscular Blocking Agent Vecuronium in Patients with Liver Dysfunction: Muscle Relaxants and Liver Dysfunction by Ashraf Dahaba (Author) The main rout of excretion of the aminosteroid non-depolarizing neuromuscular blocking drug vecuronium bromide is through hepatic metabolism. Using the Relaxometer mechanomyograph we assessed the effect of various grades of liver dysfunction on vecuronium bromide pharmacodynamics in 21 patients with mild liver dysfunction and 4 patients with severe liver dysfunction compared with 20 subjects with normal liver function. There was no significant difference in the intubation score or onset time (time from the beginning of vecuronium administration till maximal neuromuscular block) between patients with or without liver dysfunction. The Clinical Duration (time from the beginning of vecuronium administration till 25% first twitch T1 recovery), Recovery Index (time from 25% to 75% T1 recovery),... |
 |
Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment by Vicente Arroyo (Author), Pere Ginès (Author), Juan Rodés (Author), Robert W. Schrier (Author) Univ. of Barcelona, Spain. Focuses on the clinical management of ascites and related disorders in patients with chronic liver disease. Includes a description of pathophysiologic mechanisms that are key to understanding renal dysfunction and ascites formation in cirrhosis. For gastroenterologists, hepatologists, and nephrologists. DNLM: Liver Diseases--complications. |
 |
Liver Transplantation - Official Journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society by John Fung (Editor), Jorge Rakela (Editor) Includes articles on: Use of Anticoagulant Therapy Among Patients Awaiting Liver Transplantation; Bone Marrow Transplantation From Donor Immune To HBV May Confer Specific Immunity To HBV (Adoptive Immunity) To A HBV Infected Recipient and Clear HBV Infection; HLA Mismatching As A Risk Factor For PBC Recurrence; Comparison Of Outcomes In HCV Infected Recipients Of LDLT Vesus DDLT; Risk Factors Associated With New Onset Diabetes Mellitus (NODM) After Liver Transplantation |
 |
OL Medical - SAMe Gold 400mg 30t by OL Medical Division OL Medical - SAMe Gold 400mg 30t |
|
Liver dysfunction and jaundice in pregnancy (Medical Grand Rounds) by Burton Combes (Author) | |
|
Ascites And Renal Dysfunction In Liver Disease by Pere Gines (Author) | |
 |
L-Carnitine 500 mg, 30 Caps by Club Natural Note: We cannot ship carnitine to Austria, Canada and Germany. Carnitine facilitates the metabolism of carbohydrates and enhances the rate of oxidative phosphorylation. Carnitine works synergistically with Co-Q10, an antioxidant and energy co-factor that is found in the inner membrane of the mitochondria. CarniPure Carnitine is manufactured by Lonza, the industry leader offering the finest Carnitine in the world. Also consider Mind Power Rx, a brain support product with l-carnitine formulated by Ray Sahelian, M.D. For better vision, see Eyesight Rx which usually works within hours. |
| © 2009 BrightSurf.com |